VELORIN

This brand name is authorized in Albania, Cyprus, Malta, Singapore.

Active ingredients

The drug VELORIN contains one active pharmaceutical ingredient (API):

1	Atenolol UNII 50VV3VW0TI - ATENOLOL
	Atenolol is a beta-blocker which is beta1-selective, (i.e. acts preferentially on beta1-adrenergic receptors in the heart). Atenolol is without intrinsic sympathomimetic and membrane-stabilising activities and as with other beta-blockers, has negative inotropic effects.
	Read more about Atenolol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
VELORIN Film-coated tablet	MPI, EU: SmPC	Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C07AB03	Atenolol	C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective
Discover more medicines within C07AB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AL	Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor	73/110
MT	Medicines Authority	AA084/09503
SG	Health Sciences Authority	06924P